Feasibility of dose painting using volumetric modulated arc optimization and delivery

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 964-971

  Korreman, Stine S ^a,b,c   Ulrich, Silke ^b   Bowen, Steve ^a   Deveau, Michael ^a   Bentzen, Søren M ^a,b   Jeraj, Robert ^a,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSE CALCULATION; HEAD AND NECK CANCER; PATIENT POSITIONING; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

CALIBRATION; CARCINOMA, SQUAMOUS CELL; CONE-BEAM COMPUTED TOMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HUMANS; ORGANOMETALLIC COMPOUNDS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; THIOSEMICARBAZONES; TONGUE NEOPLASMS;

EID: 77956608281     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.498440     Document Type: Article

References (23)

1. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomo-geneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653-666
2. Webb S, Evans PM, Swindell W, Deasy JO. A proof that uniform dose gives the greatest TCP for fi xed integral dose in the planning target volume. Phys Med Biol 1994; 39:2091-2098
3. Levin-Plotnik D, Hamilton RJ. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols. Phys Med Biol 2004; 49:407-424
4. Brahme A, Agren AK. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 1987;26:377-385
5. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-560
6. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:1171-1182
7. Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:112-117
8. Yang Y, Xing L. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys 2005;32:3666-3677
9. Malinen E, Sovik A, Hristov D, Bruland OS, Olsen DR. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006;51:4903-4921
10. Bowen SR, Flynn RT, Bentzen SM, Jeraj R. On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function. Phys Med Biol 2009;54:1483-1501
11. Flynn RT, Bowen SR, Bentzen SM, Rockwell MT, Jeraj R. Intensity-modulated X-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol 2008;53:4153-4167
12. Vanderstraeten B, Duthoy W, De GW, De NW, Thierens H. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radi-other Oncol 2006;79:249-258
13. Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009;48:1181-1192
14. Bentzen SM. Dose painting and theragnostic imaging: Towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res 2008;139:41-62.
15. Busk M, Horsman MR, Overgaard J. Resolution in PET hypoxia imaging: Voxel size matters. Acta Oncol 2008;47: 1201-1210
16. Thorwarth D, Soukup M, Alber M. Dose painting with IMPT, helical tomotherapy and IMXT: A dosimetric comparison. Radiother Oncol 2008;86:30-34
17. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005;77:18-24.
18. Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 2006;24:727-735
19. Deveau M, Bowen SR, Westerly D, Jeraj R. Feasibility study of helical TomoTherapy for dose painting. Med Phys 2009;36:2783-2784
20. Korreman S, Medin J, Kjaer-Kristoffersen F. Dosimetric Verification of RapidArc treatment delivery. Acta Oncol 2009;48:185-191
21. Ceberg S, Gustafson H, Korreman S, Medin J, Kjær-Kristoffersen F, Bäck S. RapidArcTM treatment Verification using polymer gel dosimetry. J Phys: Confer Ser 2008;164: 012052, IOP Publishing.
22. Grau C, Muren LP, Hoyer M, Lindegaard J, Overgaard J. Image-guided adaptive radiotherapy-integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182-1185
23. Tanderup K, Olsen DR, Grau C. Dose painting: Art or science? Radiother Oncol 2006;79:245-248